Please login to the form below

Not currently logged in
Email:
Password:

Parexel signs drug development collaboration with Taiwanese hospital

Will work with the National Taiwan University Hospital

Parexel has formed an alliance with a leading Taiwanese hospital to provide drug development services in the country.

The deal with the National Taiwan University Hospital (NTUH) continues the contract research organisation's (CRO) expansion in Asia as it seeks to position itself to work more with both local and global biopharmaceutical companies.

Joe Avellone, corporate senior vice president of clinical research services at Parexel, said: “Partnering with National Taiwan University Hospital further enhances our ability to meet the increasing demand from our clients to provide a full scope of phase I-IV clinical trials in a rapidly growing market.

“The National Taiwan University Hospital is well-known and highly respected in Taiwan. We are pleased to have the opportunity to work together to advance our biopharmaceutical clients' programmes in the region and help them to compete more effectively in the global marketplace.”

The CRO said its latest collaboration would “drive greater efficiency” for trial sponsors and help the partners create innovative development and marketing solutions for the region.

Ming-Fong Chen, superintendent at NTUH, said: “This partnership will bring opportunities for both Parexel and NTUH to leverage our combined expertise in order to accelerate clinical development programmes in Taiwan and meet patients' need for more effective treatments.”

The deal follows two agreements in nearby South Korea. In February, Parexel joined up with Seoul's ASAN Medical Center (AMC) to expand the clinical trial services it offers throughout Asia.

Then in July, the CRO was subsequently chosen by government consortium the Korea Drug Development Fund (KDDF) to help Korean companies develop and commercialise healthcare products for the global market.

29th November 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics